Platelet Aggregation Devices Market by Product, Application, End User - Global Forecasts to 2020

The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) hold large shares in the global platelet aggregation devices market, and the North American region (particularly the U.S.) is expected to grow at the highest CAGR in the forecast period. Overall growth in the global platelet aggregation devices market is driven by the rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies. However, factors such as procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are restraining the growth of this market. In addition, stringent regulatory policies and limited medical reimbursements are posing significant challenges for the growth of the platelet aggregation devices market.

In this report, the global platelet aggregation devices market is segmented on the basis of products (systems, reagents, and consumables and accessories), applications (research applications and clinical applications), and end users (standalone hospitals, diagnostic laboratories, research and academic institutes, and other end users). The systems segment is expected to account for the largest share of the global platelet aggregation products market in 2015, followed by the reagents segment. Factors such as continuous technological advancements in the field of sensors and detectors, rising trend of automation of platelet aggregation testing procedures, growing adoption and market preference for automated instruments among diagnostic laboratories, and improved patient compliance offered by point-of-care testing analyzers as compared to conventional instruments are driving the growth of the platelet aggregation systems market.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global platelet aggregation devices market in 2015, followed by Europe. North America is also poised to grow at the highest CAGR during the forecast period, owing to factors such as large patient population for target diseases, strong presence of device manufacturers, growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders. The global platelet aggregation devices market is moderately competitive with the presence of various global as well as local players. As of 2014, the global platelet aggregation devices market was dominated by F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), and Accriva Diagnostics (U.S.), that together accounted for ~85.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions and divestments are the major strategies adopted by most of the market players to achieve growth in the global platelet aggregation devices market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the platelet aggregation devices market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on platelet aggregation products offered by the top 10 players in the global platelet aggregation devices market. The report analyzes the platelet aggregation devices market by product, application, and end user across key geographic regions

‧ Product Development/Innovation: Detailed insights on upcoming platelet aggregation testing technologies, research and development activities, and new product launches in the global platelet aggregation devices market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various platelet aggregation products across key geographic regions

‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global platelet aggregation devices market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global platelet aggregation devices market

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Breakdown of primaries 22
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 RESEARCH ASSUMPTIONS 26
2.4.1 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
3.1 INTRODUCTION 27
3.2 CURRENT MARKET SCENARIO 27
3.3 FUTURE OUTLOOK 28
3.4 CONCLUSION 30
4 PREMIUM INSIGHTS 31
4.1 GLOBAL PLATELET AGGREGATION DEVICES MARKET, 2015–2020 31
4.2 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY REGION (2015–2020) 32
4.3 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT (2015) 33
4.4 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION (2015–2020) 34
4.5 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY END USER (2015–2020) 35
?
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.3 MARKET DYNAMICS 38
5.3.1 KEY MARKET DRIVERS 39
5.3.1.1 Rising incidence of target diseases 39
5.3.1.2 Rapid growth in the geriatric population across the globe 39
5.3.1.3 Technological advancements in platelet aggregometers 40
5.3.1.4 Increasing number of industry-academia collaborations and clinical studies 41
5.3.2 KEY MARKET RESTRAINTS 42
5.3.2.1 Procedural limitations 42
5.3.2.2 Unfavorable healthcare reforms in the U.S. 43
5.3.2.3 Dearth of well-trained, skilled, and experienced professionals 43
5.3.3 KEY MARKET OPPORTUNITIES 44
5.3.3.1 Emerging markets 44
5.3.3.2 Advent of point-of-care & miniaturized platelet aggregometers 45
5.3.4 KEY MARKET CHALLENGES 46
5.3.4.1 Stringent regulatory policies 46
5.3.4.2 Limited medical reimbursements 47
6 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT 48
6.1 INTRODUCTION 49
6.2 SYSTEMS 50
6.3 REAGENTS 51
6.4 CONSUMABLES AND ACCESSORIES 52
7 PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION 53
7.1 INTRODUCTION 54
7.2 CLINICAL APPLICATIONS 55
7.2.1 CARDIOVASCULAR APPLICATIONS 57
7.2.2 ORTHOPEDIC APPLICATIONS 58
7.2.3 OTHER CLINICAL APPLICATIONS 59
7.3 RESEARCH APPLICATIONS 60
8 PLATELET AGGREGATION DEVICES MARKET, BY END USER 62
8.1 INTRODUCTION 63
8.2 STANDALONE HOSPITALS 64
8.3 DIAGNOSTIC LABORATORIES 66
8.4 RESEARCH AND ACADEMIC INSTITUTES 67
8.5 OTHER END USERS 68
9 PLATELET AGGREGATION DEVICES MARKET, BY REGION 70
9.1 INTRODUCTION 71
9.2 NORTH AMERICA 72
9.2.1 U.S. 75
9.2.2 CANADA 77
9.3 EUROPE 80
9.3.1 GERMANY 83
9.3.2 U.K. 85
9.3.3 FRANCE 87
9.3.4 REST OF EUROPE (ROE) 88
9.4 ASIA-PACIFIC 90
9.4.1 JAPAN 92
9.4.2 CHINA 94
9.4.3 INDIA 96
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 98
9.5 REST OF THE WORLD (ROW) 100
10 COMPETITIVE LANDSCAPE 102
10.1 OVERVIEW 102
10.2 MARKET SHARE ANALYSIS 103
10.3 COMPETITIVE SCENARIO 104
10.4 RECENT DEVELOPMENTS 105
10.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 105
10.4.2 ACQUISITIONS AND DIVESTMENTS 107
10.4.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 108
10.4.4 GEOGRAPHICAL EXPANSIONS 109
10.4.5 OTHER DEVELOPMENTS 109
11 COMPANY PROFILES 111
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 111
11.1.1 GEOGRAPHIC REVENUE MIX 111
11.1.2 STRATEGIC BENCHMARKING 112
11.1.2.1 Product development and commercialization 112
11.2 F. HOFFMAN-LA ROCHE LTD. 113
11.3 HAEMONETICS CORPORATION 115
11.4 SYSMEX CORPORATION 117
11.5 SIEMENS AG 119
11.6 ACCRIVA DIAGNOSTICS 121
11.7 HELENA LABORATORIES CORPORATION 122
11.8 BIO/DATA CORPORATION 123
11.9 SENTINEL CH. S.P.A. 125
11.10 TEM GROUP 126
11.11 AGGREDYNE, INC. 128

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 130
12.1 INSIGHTS OF INDUSTRY EXPERTS 130
12.2 DISCUSSION GUIDE 131
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
12.4 AVAILABLE CUSTOMIZATIONS 135
12.5 RELATED REPORTS 136